JE
Oblique Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Proprietary Pain Program(s) | Pain | Pre-clinical |
| Proprietary Oncology Program(s) | Aggressive-metastatic cancer | Pre-clinical |
| Eli Lilly Collaboration | Undisclosed | Discovery |
| Animal Health Company Collaboration | Veterinary (Undisclosed) | Discovery |